Much of the discussion of ethical issues in therapeutic research on children is based on the application of general moral principles to categories of problems. The authors believe that this approach does not adequately address the complexity of a treatment regimen for catastrophically ill children which is both therapeutic and research oriented. Using a case study to illustrate the potential complications of such a situation, they argue that medical paternalism is justified in therapeutic research on children even if it diminishes the patients autonomy, on the grounds that the best interests of the patient must take precedence over preservation of complete autonomy. (KIE abstract) ...
New life-saving treatments for Atrial fibrillation in clinical trial on Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II - ORBIT AF II - Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF II) is designed to evaluate the utilization of target-specific antithrombotic agents, such as factor Xa (FXa) inhibitors and direct thrombin inhibitors, and associated outcomes.
[email protected] wrote: , , I have recently been diagnosed w/ pulmonary adenocarcinoma of the , bronchoalveolar type ( I believe). The only treatment being discussed by my , physician is chemotherapy (a combination of taxol and carboplatin). The two , doctors I have consulted differed in their opinion regarding how much time , this treatment might offer, but it may only improve the quality of my life for , a matter of months. Obviously, I am interested in what is ongoing as far as , treatment alternatives and/or clinical trials. Have recently contracted w/ , Best Doctors for info re:whos doing the best work w/ this illness, but have , received no reports and been encouraged to investigate clinical trials. \ , , Please forward any relevant information you might have so that my husband and , I can make better informed treatment decisions. , , Thank you, , Eloise Hendryx , , ps I am new to using the Internet and e-mail , ------------------------------------------------------------------------ , ...
The National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 27 leading cancer centers devoted to patient care, research, and education, is dedicated to improving the quality, effectiveness, and efficiency of cancer care so that patients can live better lives. Through the collaborative expertise of its member institutions, the NCCN develops, evaluates, and disseminates practice guidelines to support health professionals and patients in making informed treatment decisions.
DOWNLOAD A CORPORATE EVENT BROCHURE » The American Childhood Cancer Organization (ACCO) is a non-profit organization that provides FREE RESOURCES to families who have a child diagnosed with cancer, to assist them with making informed treatment decisions during the difficult childhood cancer journey. We can only provide these vital materials through the generosity and support of our community and corporate partners.. ...
PremierTox laboratory combines industry leading toxicology testing services while advocating on behalf of the patient. Equipping Clinicians to make informed treatment decisions, reducing prescription diversion and abuse.
Antigen test reliably and quickly triages people suspected of SARS-CoV-2, with results ready in 15 minutes, allowing informed treatment decisions Antigen test accurately screens individuals with known exposure to infected SARS-CoV-2 patients, providing fast answers regarding their infection status Affordable and small, instrument-free testing kit enables convenient use for healthcare professionals at different point of…. ...
Helping men newly diagnosed with early-stage prostate cancer make the most informed treatment decision for their disease, including active surveillance.
Cancer Monthly provides information about 100s of cancer treatments so that patients can compare therapy differences, longest survival rates, toxicity, side effects, hospitals, and many other facts, to have more meaningful discussions with their doctors, and ultimately, make more informed treatment decisions.
Cancer Monthly provides information about 100s of cancer treatments so that patients can compare therapy differences, longest survival rates, toxicity, side effects, hospitals, and many other facts, to have more meaningful discussions with their doctors, and ultimately, make more informed treatment decisions.
The registry is aimed at establishing national benchmarks for stereotactic radiosurgery (SRS) treatments in order to provide clinicians and patients the data they need to make informed treatment decisions. Data from 30 diverse, high-volume sites will produce information from thousands of patients with brain metastases, benign brain tumors and arteriovenous malformations (AVMs).
So tomorrow is the big day; my fifth needle core biopsy. Rather like a space probe, the purpose of this procedure is to look closer; to learn more about the nature of my cancer so that we may make informed treatment decisions. My very first biopsy was the most memorable. Four days earlier I had…
BioMarin (http://www.biomarinpharm.com/). Phenoptin™ (BH4): BioMarin initiates Phase 3 Clinical Trial of Phenoptin™ for PKU. Novato, CA, April 7, 2005 - BioMarin Pharmaceutical Inc. (Nasdaq and SWX: BMRN) announced today that it has randomized the first patient in its Phase 3 clinical trial of Phenoptin™ (sapropterin hydrochloride), an investigational oral, small molecule therapeutic for the treatment of the genetic disease phenylketonuria (PKU). The company expects to announce data from this trial in the second half of 2005. ...
TY - JOUR. T1 - Endothelin in human cerebrospinal fluid. AU - Shirakami, G.. AU - Nakao, K.. AU - Saito, Y.. AU - Magaribuchi, T.. AU - Nagata, H.. AU - Jougasaki, M.. AU - Mukoyama, M.. AU - Arai, H.. AU - Hosoda, K.. AU - Suga, S.. AU - Ogawa, Yoshihiro. AU - Mori, K.. AU - Imura, H.. PY - 1990/12/1. Y1 - 1990/12/1. UR - http://www.scopus.com/inward/record.url?scp=0025651382&partnerID=8YFLogxK. UR - http://www.scopus.com/inward/citedby.url?scp=0025651382&partnerID=8YFLogxK. M3 - Article. AN - SCOPUS:0025651382. VL - 11. SP - 111. EP - 116. JO - Therapeutic Research. JF - Therapeutic Research. SN - 0289-8020. IS - 12. ER - ...
The ORBIT-AF registry is a multicenter prospective outpatient disease registry of patients with incident (initial diagnosis) or prevalent (existing diagnosis) atrial fibrillation (AF) that will analyze treatment patterns and outcomes in patients with AF in the US. Approximately 10,000 prospective cohort of patients will be enrolled. The registry will be a nation-wide collaboration of Health Care Providers (e.g., cardiologists, internists, primary care physicians, electrophysiologists, quality improvement personnel, office/practice managers, research coordinators, and pharmacists). This collaborative effort will be focused on the optimization of outpatient management of patients with AF. Consecutive patients who meet the eligibility criteria will be approached and educated about the registry. Patients who express interest will provide informed consent. Patients enrolled in the registry will be followed for approximately 3 years. Patient follow-up by their AF care provider will continue as ...
The ORBIT-AF registry is a multicenter prospective outpatient disease registry of patients with incident (initial diagnosis) or prevalent (existing diagnosis) atrial fibrillation (AF) that will analyze treatment patterns and outcomes in patients with AF in the US. Approximately 10,000 prospective cohort of patients will be enrolled. The registry will be a nation-wide collaboration of Health Care Providers (e.g., cardiologists, internists, primary care physicians, electrophysiologists, quality improvement personnel, office/practice managers, research coordinators, and pharmacists). This collaborative effort will be focused on the optimization of outpatient management of patients with AF. Consecutive patients who meet the eligibility criteria will be approached and educated about the registry. Patients who express interest will provide informed consent. Patients enrolled in the registry will be followed for approximately 3 years. Patient follow-up by their AF care provider will continue as ...
The A4 Study is a landmark public-private partnership, funded by the National Institute on Aging/NIH, Eli Lilly and Company, and several philanthropic organizations. The A4 trial is coordinated by the University of Southern Californias Alzheimers Therapeutic Research Institute, with study sites in multiple locations ...
ACTIV aims to promote clinical and epidemiologic studies, diagnostic and therapeutic research into pediatric diseases : nasopharyngeal carriage of pneumococcus, national observatory of bacterial meningitis in children, observatory of pneumonia, observatory of chickenpox, observatory of invasive pneumococcal disease...
Over the next three decades, Pickett remained embedded in industry, although the names and places changed as he progressed upward. After his initial assignment serving with Alberts on the development team working on the first generation HMG-CoA reductase inhibitors (statins), Pickett soon rose to the position of director of the department of molecular pharmacology and biochemistry. In 1988, he moved to Montreal to become the head of research at the Merck Frosst Centre for Therapeutic Research, where, among other duties, he recruited bright scientific minds - looking for the next Cecil Pickett, as it were. It was during his tenure that Merck Frosst researchers discovered the asthma drug Singulair. (Homage to the site of discovery can be found in the drugs scientific name, Montelukast).. "It was becoming obvious to Merck that Cecil could lead any drug research group," says Vagelos about his longtime colleague, "and unfortunately for Merck this was becoming apparent to others as well.". In 1993, ...
Plasticell, the biotechnology company specialising in stem cell screening and cell therapy development, has entered into a collaboration with GSK to use its combinatorial stem cell screening technology, CombiCult®, to optimise the directed differentiation of induced pluripotent stem cells (iPSCs) to specific blood cell lineages for use by GSK in its therapeutic research.. In the collaboration, Plasticell will use its CombiCult® technology to screen combinations of molecules provided by GSK to identify and optimise iPSC differentiation protocols. Plasticells proprietary technology will allow the simultaneous screening of multiple iPSC lines, facilitating the development of a robust protocol that is applicable across lines.. Commenting on the collaboration, Plasticells founder and Executive Chairman, Dr Yen Choo, said: "During the course of developing its therapeutic programmes, Plasticell has acquired considerable expertise in pluripotent and hematopoietic stem cells, the derivation of ...
Diarrhea-Mechanism of action Insights, 2017, the report provides comprehensive insights of the ongoing therapeutic research and development across Diarrhea. The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Diarrhea by development stage, therapy type, route of administration and molecule type is also covered in the report. It also has a special feature on the inactive pipeline products in this area.
AceProbe has been diligently working towards its mission to develop genetic solutions that are evolving as paradigms for futuristic medicine in their role for comprehensive disease detection and informed treatment, ushering in a new era of predictive, preventative and affordable health care.The company continues to support healthcare providers with its expertise and knowledgebase to go…
2011-2016 University of Minnesota Press , Privacy Policy , The University of Minnesota is an equal opportunity educator and employer.. ...
Issuu is a digital publishing platform that makes it simple to publish magazines, catalogs, newspapers, books, and more online. Easily share your publications and get them in front of Issuus millions of monthly readers. Title: The New York Academy of Sciences Magazine, Fall 2017, Author: The New York Academy of Sciences, Name: The New York Academy of Sciences Magazine, Fall 2017, Length: 32 pages, Page: 24, Published: 2017-10-30
Get this from a library! Medicine and mankind : lectures to the laity delivered at the New York Academy of Medicine. [Eugene H Pool; Iago Galdston; New York Academy of Medicine.;] -- This work contains a series of lectures from the New York Academy of Medicine, which seek to educate the public on medicine and scientific inquiry.
Organizers: Alan Cross (AstraZeneca), Sonya Dougal (formerly at The New York Academy of Sciences), Howard Feldman (University of British Columbia), Surya Kolluri (Bank of America), Ian Kremer (Leaders Engaged on Alzheimers Disease), Tetsuyuki Maruyama (Takeda), Richard C. Mohs (Eli Lilly and Company), Jeffrey S. Nye (Janssen R&D), Ronald C. Petersen (Mayo Clinic), Gregory A. Petsko (Weill Cornell Medical College), Andrea Pfeifer (AC Immune), Thomas Rooney (Sanofi), Darryle D. Schoepp (Merck and Company, Inc.), Diane Stephenson (Critical Path Institute), Rudolph E. Tanzi (Harvard Medical School), John Q. Trojanowski (University of Pennsylvania), Diana L. van de Hoef (The New York Academy of Sciences), George Vradenburg (The Global CEO Initiative on Alzheimers Disease), Michael Weiner (University of California, San Francisco), Michael Krams (Janssen R&D)NIA Technical Advisor: Neil Buckholtz (National Institute on Aging/NIH)This conference will convene leading industry, academic, and government
Organizers: Eric Lai (Memorial Sloan Kettering Cancer Center), Benjamin R. tenOever (Mount Sinai School of Medicine), Thomas Tuschl (The Rockefeller University), Jenifer Henry (The New York Academy of Sciences), Marta Murcia (The New York Academy of Sciences)This one-day event will explore the current understanding of RNA nucleases as they relate to a diverse array of cellular functions.
You searched for: Periodical Annals of the New York Academy of Sciences Remove constraint Periodical: Annals of the New York Academy of Sciences ...
You searched for: Publisher New York Academy of Sciences Remove constraint Publisher: New York Academy of Sciences Subject RNA, Transfer Remove constraint Subject: RNA, Transfer ...
This meeting report highlights the main topics presented at the conference "Chronic Inflammatory and Neuropathic Pain," convened jointly by the New York Academy of Sciences, MedImmune, and Grünenthal GmbH, on June 2-3, 2011, with the goal of providing a conducive environment for lively, informed, and synergistic conversation among participants from academia, industry, clinical practice, and government to explore new frontiers in our understanding and treatment of chronic and neuropathic pain. The program included leading and emerging investigators studying the pathophysiological mechanisms underlying neuropathic and chronic pain, and experts in the clinical development of pain therapies. Discussion included novel issues, current challenges, and future directions of basic research in pain and preclinical and clinical development of new therapies for chronic pain. ...
The Mechanisms of Cell Division: Annals of the New York Academy of Sciences, V51 by Milan James Kopac available in Trade Paperback on Powells.com, also read synopsis and reviews. Contributing Authors Include Edwin G. Conklin, Warren H. Lewis, Albert J. Dalton, And Many Others.
All about Recombinant DNA Technology II (Annals of the New York Academy of Sciences) by Ales Prokop. LibraryThing is a cataloging and social networking site for booklovers
NODEN, D. M. (1990), Origins and Assembly of Avian Embryonic Blood Vessels. Annals of the New York Academy of Sciences, 588: 236-249. doi: 10.1111/j.1749-6632.1990.tb13214.x ...
This volume of the book examines various approaches to neuroprotection, including methods for neuroprotection, mechanisms involved in neuroinjury, pharmacologic agents associated with neuroprotection. * Features proceedings of the Ninth International Conference on Neuroprotective Agents * Part of the Annals of the New York Academy of Sciences series * This book is ideal for graduate students, researchers and clinicians in neuroscience and neurology. NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit www.blackwellpublishing.com/nyas. ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order (www.nyas.org). Members of the New York Academy of Science receive full-text access to the Annals online and discounts on print volumes. Please visit http://www.nyas.org/MemberCenter/Join.aspx for more information about becoming a member.
Do you have a chronic disease? Do you want to live well? You can improve your health and well-being by participating in the Chronic Disease Self-Management Program (CDSMP) otherwise known as "Live Well, Virginia!" This FREE 6-week series begins January 10 and goes to February 21st, 2020 (Note that there is no class Jan. 17 due to Virginia state holiday). Classes begin 10 a.m. and finish at noon at the dRC. CDSMP is an evidence-based self-management program that was developed at Stanford University and sessions are led by two trained volunteers.. While medical advice is not given to participants, many self-management topics are covered. These topics include working with your health care professional, dealing with depression, making informed treatment decisions, medication usage, communication skills, healthy eating, better breathing techniques, pain and fatigue management, preventing falls, making decisions, physical activity, dealing with difficult emotions, problem-solving, making an action ...
Subscribe (free) In patients suffering from Type 1 diabetes At CTCA we provide our cancer survival rates and statistics to help you make more informed treatment decisions. Padre Coffee swedishs Pancreas Transplant Team is dedicated to restoring patients requiring lifelong insulin therapy to their optimum health by combining individualized Enlarged spleen Learn about spleen location spleen pain and other symptoms and possible causes and treatments for splenomegaly. good exercises to burn belly fat.. No Manual da Diabetes voc encontra todas as informaes soe Diabetes como tratamentos dietas dicas para viver melhor e muito mais. Health A new study conducted at the University of California revealed that low levels of vitamin D in the blood might Wie entsteht eigentich das HbA1c was bedeutet der Name und warum nennt man es auch den Langzeit-Blutzuckerspiegel? Type 2 diabetes tends to affect people as they Pancreatitis Aguda I parte. Diabetes Specialist in Las Vegas NV Health Gorilla is the first ...
Focusing on immunology and scientific research in the broadest sense, I am also inspired by Professor Peter Doherty. He shared the Nobel Prize in Physiology or Medicine in 1996 with Swiss colleague Rolf Zinkernagel, for their discovery of how the immune system recognizes virus-infected cells. His research is mainly in the area of defense against viruses. He regularly devotes time to delivering public lectures, writing articles for newspapers and magazines and participating in radio discussions, which are a real treat. Below, Id like to capture some of his introductory thoughts around immunology.. Immunology is the branch of biomedical sciences concerned with all aspects of the immune system in all multicellular organisms. Biomedical researchers probe the mechanistic basis of health and disease. Recently the field sees an extraordinary (and continuing) revolution in medical understanding and human well-being. Researchers gain deeper understanding into how our specific (or adaptive) immune ...
The scientific research presented in this volume captures where the field stands after 10 years of intense research by the MacArthur Network and others into the mechanisms of health disparities. In addition, it illustrates the power of a multidisciplinary approach to complex social issues. Finally, it presents potential applications of the accumulated knowledge for social interventions and raises pragmatic issues that are important to consider when science is translated into policy and intervention.. NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit www.blackwellpublishing.com/nyas.. ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order (www.nyas.org). Members of the New York Academy of Science receive full-text access to the Annals online and discounts on print volumes. Please visit http://www.nyas.org/MemberCenter/Join.aspx for more information about ...
DeGarmo, D. S., & Capaldi, D. M. (1999). Social class as a moderator of income effects on health outcomes across nine years. In N. E. Alder, M. Marmot, B. S. McEwen, & J. Stewart Socioeconomic status and health in industrial nations: Social, psychological, and biological pathways (Annals of the New York Academy of Sciences ed. Vol. 896, pp 318-321). New York: The New York Academy of Sciences.. ...
DeGarmo, D. S., & Capaldi, D. M. (1999). Social class as a moderator of income effects on health outcomes across nine years. In N. E. Alder, M. Marmot, B. S. McEwen, & J. Stewart Socioeconomic status and health in industrial nations: Social, psychological, and biological pathways (Annals of the New York Academy of Sciences ed. Vol. 896, pp 318-321). New York: The New York Academy of Sciences.. ...
In: Types of alcoholics: Evidence from clinical, experimental, and genetic research., vol. Annals of the New York Academy of Sciences, Vol. 708., pp. 7 --22, New York Academy of Sciences, New York. (ISBN: 0-89766-799-9 (hardcover); 0-89766-800-6 (paperback)). Allen, JP, Fertig, JB, Mattson, ME, Babor, T, and Hesselbrock, V (1994 ...
Once cooled to safely below the glass transition temperature, there is no known time limit beyond which safe storage cannot continue[6]. Therefore, the possibility of successfully reviving would-be time travelers must be considered in the light of technological advances of the indefinite future. Assuming technological progress continues until fundamental physical limits are reached, any required repair process that is consistent with physical law should become available to rescue contemporary people.. In considering the possibility of repair, we can distinguish between two fundamentally different kinds of injury. The first kind of injury involves, in essence, the rearrangement, misfolding, or chemical modification of the molecules constituting the patient, but especially of molecules constituting the patients brain. The reversal of this kind of injury will require the ability to recognize and correct molecular changes. The fact that biological systems already perform these functions on a ...
You can submit your resume by visiting this link. If you know anyone who would be a great fit for this position, please pass the link along. Thanks!
TY - JOUR. T1 - Antirapsyn antibodies in chronic procainamide-associated myopathy (CPAM). AU - Agius, Mark A.. AU - Zhu, Shan. AU - Fairclough, Robert H. PY - 1998. Y1 - 1998. UR - http://www.scopus.com/inward/record.url?scp=0031927908&partnerID=8YFLogxK. UR - http://www.scopus.com/inward/citedby.url?scp=0031927908&partnerID=8YFLogxK. U2 - 10.1111/j.1749-6632.1998.tb10975.x. DO - 10.1111/j.1749-6632.1998.tb10975.x. M3 - Article. C2 - 9668287. AN - SCOPUS:0031927908. VL - 841. SP - 527. EP - 529. JO - Annals of the New York Academy of Sciences. JF - Annals of the New York Academy of Sciences. SN - 0077-8923. ER - ...
TY - JOUR. T1 - Round table 2. Consensus on postnatal deficits. T2 - Comparability of human and animal findings. AU - Slotkin, T.. AU - Spear, L.. AU - Harvey, J. A.. AU - Chiriboga, C. A.. AU - Mayes, L.. AU - Richardson, G.. AU - Lester, B.. AU - Blitz, R.. AU - Koren, G.. AU - Ferreiro, D.. AU - Bauer, Charles R. AU - Kosofsky, B. E.. PY - 1998/8/18. Y1 - 1998/8/18. UR - http://www.scopus.com/inward/record.url?scp=0032555033&partnerID=8YFLogxK. UR - http://www.scopus.com/inward/citedby.url?scp=0032555033&partnerID=8YFLogxK. U2 - 10.1111/j.1749-6632.1998.tb09733.x. DO - 10.1111/j.1749-6632.1998.tb09733.x. M3 - Article. C2 - 9668404. AN - SCOPUS:0032555033. VL - 846. SP - 153. EP - 157. JO - Annals of the New York Academy of Sciences. JF - Annals of the New York Academy of Sciences. SN - 0077-8923. ER - ...
Painting meticulously and only from life imposes on the artist a set of exacting conditions that precludes many possibilities. If you have to be there to paint something and it takes you a long time to paint it, then that thing has to sit still and not change very much over time. Murphy has gone to great and sometimes perverse lengths to finish paintings: freezing food items in between painting sessions over the course of months, propping up fallen trees with pulley systems, commissioning taxidermied wildlife. Elements of the close at hand also have to stand in for the faraway, and the meaning of an artwork must be generated from precisely this quotidian stuff. In the years since the stripped-down, formalist revival of figuration in the 1960s, Murphy has embraced a more full-bodied idea of content precisely through her adherence to the dictates of patient observation. As much as her paintings are concerned with breaking down the everyday into its abstract components, they also reassemble this ...
TY - JOUR. T1 - BILAYER SENSOR MODEL OF ERYTHROCYTE SHAPE CONTROL. AU - Sheetz, Michael. AU - Alhanaty, Eytan. PY - 1983/1/1. Y1 - 1983/1/1. UR - http://www.scopus.com/inward/record.url?scp=0020974019&partnerID=8YFLogxK. UR - http://www.scopus.com/inward/citedby.url?scp=0020974019&partnerID=8YFLogxK. U2 - 10.1111/j.1749-6632.1983.tb35178.x. DO - 10.1111/j.1749-6632.1983.tb35178.x. M3 - Article. C2 - 6587819. AN - SCOPUS:0020974019. VL - 416. SP - 58. EP - 65. JO - Annals of the New York Academy of Sciences. JF - Annals of the New York Academy of Sciences. SN - 0077-8923. IS - 1. ER - ...
What made Excerpta Medica such an inspired choice is that it is a branch of the academic publisher, Reed Elsevier Plc., which publishes many of the worlds most prestigious science journals. Excerpta Medica manages two journals itself: Clinical Therapeutics and Current Therapeutic Research. According to court documents, Excerpta Medica planned to submit most of the articles it produced to Elsevier journals. In the actual event, Excerpta managed to publish only two articles before Fen-Phen was withdrawn from the market in 1997. One appeared in Clinical Therapeutics, the other in the American Journal of Medicine (another Elsevier journal). In neither case did the authors of the articles disclose that they were paid by Excerpta Medica. So clean was the laundering operation, in fact, that many of the authors did not even realize that Wyeth was involved. Richard Atkinson of the University of Wisconsin wrote a letter to Excerpta Medica congratulating them on the thoroughness and clarity of their ...
1 Prevalence of dementia by age. From Jorm AF, Korten AE, Henderson AS. The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatrica Scandinavica 1987; 76: 465-79. 1). An ageing population means that dementia is on the increase. This should allow planners and politicians to forecast needs and hopefully to develop services. In the UK there are currently over 750 000 people with dementia. 8 million by 2050. Because of its economic impact, dementia is an important target for diagnostic and therapeutic research and development. Thrombolysis in stroke There is a firm evidence base that cerebral reperfusion with thrombolysis (r-tPA, Alteplase) improves recovery in selected subgroups Selected patients Thyroid function Troponin Liver function Fasting glucose Oral glucose tolerance test Chest X-ray Carotid Doppler ultrasound 37 Difficult syndromes Vasculitic screen/ immunology Echocardiogram Transcranial Doppler ultrasound Magnetic resonance imaging Cerebral angiography * ...
Placebos are everywhere in medical research, but its hard to tell if the placebos in one study are the same as those used in another study. In a new research report, a team of investigators, including STS philosopher of medicine, Dr Jeremy Howick, shows the extent of non-description about placebos. This raises concerns because, the authors write, "No substances are known to be physiologically inert, and no regulations guide placebo composition, which can influence study results." The lack of clarity about placebos can lead to confusion when comparing the results of therapeutic research. Placebos provide the baseline. If the baseline shifts with different studies, then its hard to judge the relative effectiveness of therapies.. Elaborating on their findings, Jeremy explained the problem. Perhaps due to the mistaken assumption that placebos are inactive, the ingredients of placebos are rarely divulged in any detail. Failure to adequately describe placebos leads to three problems for placebo ...